1 reports of this reaction
3.2% of all INFLUENZINUM reports
#1 most reported adverse reaction
ANGIOEDEMA is the #1 most commonly reported adverse reaction for INFLUENZINUM, manufactured by Boiron. There are 1 FDA adverse event reports linking INFLUENZINUM to ANGIOEDEMA. This represents approximately 3.2% of all 31 adverse event reports for this drug.
Patients taking INFLUENZINUM who experience angioedema should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANGIOEDEMA is moderately reported among INFLUENZINUM users, representing a notable but not dominant share of adverse events.
In addition to angioedema, the following adverse reactions have been reported for INFLUENZINUM:
The following drugs have also been linked to angioedema in FDA adverse event reports:
ANGIOEDEMA has been reported as an adverse event in 1 FDA reports for INFLUENZINUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANGIOEDEMA accounts for approximately 3.2% of all adverse event reports for INFLUENZINUM, making it one of the most commonly reported side effect.
If you experience angioedema while taking INFLUENZINUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.